A changing picture of shigellosis in southern Vietnam: Shifting species dominance, antimicrobial susceptibility and clinical presentation

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Vinh, Ha ^a,b   Nhu, Nguyen T K ^a,b   Nga, Tran V T ^a,b   Duy, Pham T ^a,b   Campbell, James I ^b,c   Hoang, Nguyen V M ^a,b   Boni, Maciej F ^b,c,d   My, Phan V T ^a,b   Parry, Christopher ^b   Nga, Tran T T ^a,b   Van Minh, Pham ^a,b   Thuy, Cao T ^a,b   Diep, To S ^b   Phuong, Le T ^e   Chinh, Mai T ^b   Loan, Ha T ^b   Tham, Nguyen T H ^e   Lanh, Mai N ^b   Mong, Bui L ^e   Anh, Vo T C ^e   Bay, Phan V B ^e   Chau, Nguyen V V ^b   Farrar, Jeremy ^a,b   Baker, Stephen ^a,b   more..

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Medical Research Council Centre for Genomics and Global Health   (United Kingdom)

^e Dong Thap Provincial Hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DYSENTERY; HUMAN; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SHIGELLA BOYDII; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; SOCIOECONOMICS; SPECIES DOMINANCE; TROPICAL DISEASE; VIET NAM; CLASSIFICATION; DRUG EFFECT; FEMALE; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PRESCHOOL CHILD; SEASON; SEROTYPING;

CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; SEASONS; SEROTYPING; SHIGELLA FLEXNERI; SHIGELLA SONNEI; VIETNAM;

EID: 74049106610     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-204     Document Type: Article

References (30)

1. Miller MA, Sentz J, Rabaa MA, Mintz ED. Global epidemiology of infections due to Shigella, Salmonella serotype Typhi, and enterotoxigenic Escherichia coli. Epidemiol Infect 2008, 136(4):433-435. 10.1017/S095026880800040X, 18461719.
2. Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol Infect 2008, 136(5):577-603. 10.1017/S0950268807009351, 17686195.
3. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999, 77(8):651-666. 2557719, 10516787.
4. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002, 347(22):1770-1782. 10.1056/NEJMra020201, 12456854.
5. Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clin Infect Dis 2004, 38(10):1372-1377. 10.1086/386326, 15156473.
6. Mates A, Eyny D, Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. Eur J Clin Microbiol Infect Dis 2000, 19(2):108-111. 10.1007/s100960050439, 10746496.
7. Clemens J, Kotloff K, Bradford K. Generic protocol to estimate the burden of Shigella diarrhoea and dysenteric mortality. The World Health Organization, Department of Vaccines and Biologicals 1999,
8. Niebuhr K, Sansonetti PJ. Invasion of epithelial cells by bacterial pathogens the paradigm of Shigella. Subcell Biochem 2000, 33:251-287.
9. Philpott DJ, Edgeworth JD, Sansonetti PJ. The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies. Philos Trans R Soc Lond B Biol Sci 2000, 355(1397):575-586. 10.1098/rstb.2000.0599, 1692768, 10874731.
10. von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh DG, Chaicumpa W, Agtini MD, Hossain A, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 2006, 3(9):e353. 10.1371/journal.pmed.0030353, 1564174,1564174, 16968124.
11. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60(5):1136-1151. 10.1111/j.1365-2958.2006.05172.x, 1557465, 16689791.
12. Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A. Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. J Clin Microbiol 2006, 44(8):2879-2883. 10.1128/JCM.00310-06, 1594633, 16891506.
13. Maurelli AT, Fernandez RE, Bloch CA, Rode CK, Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci USA 1998, 95(7):3943-3948. 10.1073/pnas.95.7.3943, 19942, 9520472.
14. Nie H, Yang F, Zhang X, Yang J, Chen L, Wang J, Xiong Z, Peng J, Sun L, Dong J, et al. Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics 2006, 7:173. 10.1186/1471-2164-7-173, 1550401, 16822325.
15. Chompook P, Samosornsuk S, von Seidlein L, Jitsanguansuk S, Sirima N, Sudjai S, Mangjit P, Kim DR, Wheeler JG, Todd J, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 2005, 83(10):739-746. 2626425, 16283050.
16. Vinh H, Wain J, Chinh MT, Tam CT, Trang PT, Nga D, Echeverria P, Diep TS, White NJ, Parry CM. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid. Trans R Soc Trop Med Hyg 2000, 94(3):323-326. 10.1016/S0035-9203(00)90343-2, 10975012.
17. CLSI Performance Standards For Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. 2007, 27(1). CLSI.
18. Agtini MD, Soeharno R, Lesmana M, Punjabi NH, Simanjuntak C, Wangsasaputra F, Nurdin D, Pulungsih SP, Rofiq A, Santoso H, et al. The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis 2005, 5:89. 10.1186/1471-2334-5-89, 1276796, 16242013.
19. Wang XY, Du L, Von Seidlein L, Xu ZY, Zhang YL, Hao ZY, Han OP, Ma JC, Lee HJ, Ali M, et al. Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. Am J Trop Med Hyg 2005, 73(2):416-422.
20. Hien BT, Trang do T, Scheutz F, Cam PD, Molbak K, Dalsgaard A. Diarrhoeagenic Escherichia coli and other causes of childhood diarrhoea: a case-control study in children living in a wastewater-use area in Hanoi, Vietnam. J Med Microbiol 2007, 56(Pt 8):1086-1096. 10.1099/jmm.0.47093-0, 17644717.
21. Kim DR, Ali M, Thiem VD, Park JK, von Seidlein L, Clemens J. Geographic analysis of shigellosis in Vietnam. Health Place 2008, 14(4):755-767. 10.1016/j.healthplace.2007.12.003, 18296100.
22. Vinh H, Baker S, Campbell J, Hoang NV, Loan HT, Chinh MT, Anh VT, Diep TS, Phuong LT, Schultsz C, et al. Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern Vietnam. J Med Microbiol 2009, 58(Pt 2):281-283. 10.1099/jmm.0.002949-0, 19141753.
23. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1, from the World Health Organization workshop at the Centre for Health and Population Research Dhaka, Bangladesh, 16-18 February 2004. , http://whqlibdoc.who.int/publications/2005/9241592330.pdf
24. Coster TS, Hoge CW, VanDeVerg LL, Hartman AB, Oaks EV, Venkatesan MM, Cohen D, Robin G, Fontaine-Thompson A, Sansonetti PJ, et al. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect Immun 1999, 67(7):3437-3443. 116529, 10377124.
25. Katz DE, Coster TS, Wolf MK, Trespalacios FC, Cohen D, Robins G, Hartman AB, Venkatesan MM, Taylor DN, Hale TL. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect Immun 2004, 72(2):923-930. 10.1128/IAI.72.2.923-930.2004, 321603, 14742537.
26. Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 1995, 13(5):495-502. 10.1016/0264-410X(94)00011-B, 7639017.
27. Kotloff KL, Noriega FR, Samandari T, Sztein MB, Losonsky GA, Nataro JP, Picking WD, Barry EM, Levine MM. Shigella flexneri 2a strain CVD with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun 1207, 68(3):1034-1039.
28. Dutta S, Rajendran K, Roy S, Chatterjee A, Dutta P, Nair GB, Bhattacharya SK, Yoshida SI. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiol Infect 2002, 129(2):235-243. 10.1017/S0950268802007240, 12403099.
29. Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, Taylor DN, Sadoff JC, Levine MM. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 1995, 13(16):1488-1494. 10.1016/0264-410X(95)00102-7, 8578831.
30. Ferreccio C, Prado V, Ojeda A, Cayyazo M, Abrego P, Guers L, Levine MM. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol 1991, 134(6):614-627.